Brief: Lineage Cell Provides Update On OPC1 Cell Therapy Program For Treatment Of Spinal Cord Injury

Lineage Cell Therapeutics

08/12/2020 13:20

Dec 8 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS INC - PROVIDES UPDATE ON OPC1
CELL
THERAPY PROGRAM FOR TREATMENT OF SPINAL CORD INJURY
    * LINEAGE CELL THERAPEUTICS INC - MAJOR IMPROVEMENTS MADE TO
OPC1
PRODUCTION, INCLUDING TO PROCESS, PURITY, POTENCY, AND SCALE
    * LINEAGE CELL THERAPEUTICS - FILING OF PATENT APPLICATIONS
ON
PROCESS, PRODUCT WHICH, IF ALLOWED, ANTICIPATED TO HAVE
EXPIRATION DATES IN 2039 AND 2040

Source text for Eikon:  ID:nBw97zRJ8a 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))